Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy.
Saved in:
| Title: | Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy. |
|---|---|
| Authors: | Thiant S; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Division of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada., Dufresne S; Division of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Ahmad I; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Cohen S; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Delisle JS; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Fernandez-Vargas OE; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Kiss T; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Lachance S; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Roy DC; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Veilleux O; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Bernard L; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Gisela Rodriguez D; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Sauvageau G; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada., Roy J; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada. jean.roy.1@umontreal.ca.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada. jean.roy.1@umontreal.ca.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada. jean.roy.1@umontreal.ca. |
| Source: | Bone marrow transplantation [Bone Marrow Transplant] 2026 Aug; Vol. 61 (8), pp. 1041-1051. Date of Electronic Publication: 2026 Jun 09. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8702459 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5365 (Electronic) Linking ISSN: 02683369 NLM ISO Abbreviation: Bone Marrow Transplant Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42265463 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Thiant+S%22">Thiant S</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Division of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Dufresne+S%22">Dufresne S</searchLink>; Division of Microbiology and Infectious Diseases, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Ahmad+I%22">Ahmad I</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Cohen+S%22">Cohen S</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Delisle+JS%22">Delisle JS</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Fernandez-Vargas+OE%22">Fernandez-Vargas OE</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Kiss+T%22">Kiss T</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Lachance+S%22">Lachance S</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Roy+DC%22">Roy DC</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Veilleux+O%22">Veilleux O</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Bernard+L%22">Bernard L</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Gisela+Rodriguez+D%22">Gisela Rodriguez D</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Sauvageau+G%22">Sauvageau G</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada.<br /><searchLink fieldCode="AU" term="%22Roy+J%22">Roy J</searchLink>; Division of Hematology, Oncology and Cellular Therapy, Department of Medicine, Institut universitaire d'hémato-oncologie et de thérapie cellulaire, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada. jean.roy.1@umontreal.ca.; Research Centre, Hôpital Maisonneuve-Rosemont, Montréal, QC, Canada. jean.roy.1@umontreal.ca.; Faculty of Medicine, Université de Montréal, Montréal, QC, Canada. jean.roy.1@umontreal.ca. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228702459%22">Bone marrow transplantation</searchLink> [Bone Marrow Transplant] 2026 Aug; Vol. 61 (8), pp. 1041-1051. <i>Date of Electronic Publication: </i>2026 Jun 09. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8702459 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5365 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202683369%22">02683369 </searchLink><i>NLM ISO Abbreviation: </i>Bone Marrow Transplant <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42265463 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41409-026-02902-4 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1041 Titles: – TitleFull: Risk factors for EBV reactivation and impact of graft composition following GVHD prophylaxis with rabbit ATG or PTCy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Thiant S – PersonEntity: Name: NameFull: Dufresne S – PersonEntity: Name: NameFull: Ahmad I – PersonEntity: Name: NameFull: Cohen S – PersonEntity: Name: NameFull: Delisle JS – PersonEntity: Name: NameFull: Fernandez-Vargas OE – PersonEntity: Name: NameFull: Kiss T – PersonEntity: Name: NameFull: Lachance S – PersonEntity: Name: NameFull: Roy DC – PersonEntity: Name: NameFull: Veilleux O – PersonEntity: Name: NameFull: Bernard L – PersonEntity: Name: NameFull: Gisela Rodriguez D – PersonEntity: Name: NameFull: Sauvageau G – PersonEntity: Name: NameFull: Roy J IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 08 Text: 2026 Aug Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5365 Numbering: – Type: volume Value: 61 – Type: issue Value: 8 Titles: – TitleFull: Bone marrow transplantation Type: main |
| ResultId | 1 |